tirzepatide muscle loss Injections: How It Helps Treat Obesity Tirzepatide vs. Semaglutide: Which GLP-1

Thats why Allison, who is not diabetic, prediabetic, or even overweight, is on it

AstraZeneca announced the discontinuation of Byetta and Bydureon BCise as newer, more effective products have come to market

Clinical reference: In the SURMOUNT-1 trial, patients using tirzepatide 15mg lost an average of 22.5% of body weight over 72 weeks with more than 50% of participants losing 20% or more (NEJM 2022)

Similarly, committee member Bill Zamboni expressed his concerns, stating, "There are too many unknowns about this product." On the other hand, PCAC member David Pope from XiFin Pharmacy Solutions stated, "I voted yes because it's time to put this decision back in the hands of the physician and pharmacist."

These therapies should never be positioned as replacements for established antihypertensive agents such as ACE inhibitors, ARBs, or calcium channel blockers